BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28111033)

  • 1. Azathioprine therapy in a case of pediatric multiple sclerosis that was seropositive for MOG-IgG.
    Zhou Y; Huang Q; Lu T; Sun X; Fang L; Lu Z; Hu X; Kermode A; Qiu W
    J Clin Neurosci; 2017 Apr; 38():71-73. PubMed ID: 28111033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOG-IgG associated optic neuritis is not multiple sclerosis.
    Costa BKD; Passos GRD; Becker J; Sato DK
    Arq Neuropsiquiatr; 2017 Oct; 75(10):687-691. PubMed ID: 29166458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and MRI phenotype of children with MOG antibodies.
    Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
    Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different features between pediatric-onset and adult-onset patients who are seropositive for MOG-IgG: A multicenter study in South China.
    Chen L; Chen C; Zhong X; Sun X; Zhu H; Li X; Yang H; Shu Y; Chang Y; Hu X; Lu Z; Peng L; Qiu W
    J Neuroimmunol; 2018 Aug; 321():83-91. PubMed ID: 29957392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
    Jarius S; Metz I; König FB; Ruprecht K; Reindl M; Paul F; Brück W; Wildemann B
    Mult Scler; 2016 Oct; 22(12):1541-1549. PubMed ID: 26869529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ
    Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M
    Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
    Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
    Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort.
    Veselaj K; Kamber N; Briner M; Friedli C; Diem L; Guse K; Miclea A; Wiest R; Wagner F; Grabe H; Abegg M; Horn MP; Bigi S; Chan A; Hoepner R; Salmen A
    CNS Neurosci Ther; 2021 Apr; 27(4):426-438. PubMed ID: 33047894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
    Kuhle J; Pohl C; Mehling M; Edan G; Freedman MS; Hartung HP; Polman CH; Miller DH; Montalban X; Barkhof F; Bauer L; Dahms S; Lindberg R; Kappos L; Sandbrink R
    N Engl J Med; 2007 Jan; 356(4):371-8. PubMed ID: 17251533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Autoantibodies Against Myelin Oligodendrocyte Glycoprotein in Multiple Sclerosis and Related Diseases.
    Spadaro M; Meinl E
    Methods Mol Biol; 2016; 1304():99-104. PubMed ID: 25814289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paediatric multiple sclerosis and other acute demyelinating diseases.
    Rostásy K; Bajer-Kornek B
    Curr Opin Neurol; 2018 Jun; 31(3):244-248. PubMed ID: 29629942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Multiple Sclerosis: an Update.
    Otallah S; Banwell B
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):76. PubMed ID: 30229541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelin Oligodendrocyte Glycoprotein Antibody Persistency in a Steroid-Dependent ADEM Case.
    Polat İ; Yiş U; Karaoğlu P; Ayanoğlu M; Öztürk T; Güleryüz H; Kurul SH
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin oligodendrocyte glycoprotein-IgG-associated optic neuritis.
    Chun BY; Cestari DM
    Curr Opin Ophthalmol; 2018 Nov; 29(6):508-513. PubMed ID: 30281030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.